机构:[1]Department of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, People's Republic of China.[2]Department of Radiology, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.[3]Department of Radiology, Sichuan Science City Hospital, Mianyang, People's Republic of China.[4]Institute of Pathology and Southwest Cancer Center, Third Military Medical University (Army Military Medical University), Chongqing, People's Republic of China.[5]The Second People's Hospital of Guiyang (Jinyang Hospital), Guiyang, People's Republic of China.
National Key Research and Development Project (2016YFC0107101) and Zunyi
Natural Science Foundation of Innovation Cultivation Program [Project No. Zunshirencai (2020) 6].
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版:
大类|3 区医学
小类|3 区肿瘤学
第一作者:
第一作者机构:[1]Department of Radiology, Southwest Hospital, Third Military Medical University (Army Military Medical University), Chongqing, People's Republic of China.[2]Department of Radiology, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.
共同第一作者:
通讯作者:
通讯机构:[2]Department of Radiology, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.[5]The Second People's Hospital of Guiyang (Jinyang Hospital), Guiyang, People's Republic of China.
推荐引用方式(GB/T 7714):
Li Xiaoming,Yao Qiandong,Liu Chen,et al.Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?[J].Journal of hepatocellular carcinoma.2022,9:379-387.doi:10.2147/JHC.S364742.
APA:
Li Xiaoming,Yao Qiandong,Liu Chen,Wang Jian,Zhang Huarong...&Cai Ping.(2022).Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?.Journal of hepatocellular carcinoma,9,
MLA:
Li Xiaoming,et al."Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?".Journal of hepatocellular carcinoma 9.(2022):379-387